Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

Journal of Neurology

Volumn 248, Issue 8, 2001, Pages 684-689

  Berg, Daniela ^a   Siefker, Christiane ^a   Becker, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Parkinson's disease; Substantia nigra hyperechogenicity; Transcranial ultrasound; Vulnerability marker

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGED; ANTIPARKINSON AGENTS; BRAIN STEM; FEMALE; GREAT BRITAIN; HUMANS; MALE; MESENCEPHALON; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PERSONALITY TESTS; PILOT PROJECTS; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0034935922     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150170114     Document Type: Article

References (30)

1. T2 relaxation time in patients with Parkinson's disease
2. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography
3. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound
4. Iron accumulation of the substantia nigra in rats visualized by ultrasound
5. Pathogenetic studies of motor fluctuations in Parkinson's disease
6. Unchanged N-acetyl aspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy
7. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment
8. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy
9. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia
10. Magnetic resonance imaging of the midbrain in Parkinson's disease
11. Proton Magnetic Resonance spectroscopy in Parkinson's disease and atypical Parkinsonian disorders
12. Altered brain metabolism of iron as a cause of neurodegenerative diseases?
13. Iron in the Parkisonian substantia nigra
14. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease
15. Iron in the basal ganglia in Parkinson's disease. An in vitro study using X-ray absorption fine structure and cryo-electron microscopy
16. Parkinsonism: Onset, progression and mortality
17. Localised proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: A multicenter pilot study
18. Endogenuos toxins as potential etiologic agents in Parkinson's disease
19. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
20. Quantitative assessment of Parkinson's disease: Study of reliability and data reduction with an abbreviated Columbia scale
21. Magnetic resonance imaging in parkinsonism
22. Study of movement disorders and brain iron by MR
23. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders
24. Magnetic Resonance Imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy
25. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case control study in Germany
26. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
27. A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system
28. Progressive supranuclear palsy - MRI and pathological findings
29. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease